Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.
about
Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.A Simple Phosphate-Buffered-Saline-Based Extraction Method Improves Specificity of HIV Viral Load Monitoring Using Dried Blood Spots.Long-term outcomes of second-line antiretroviral treatment in an adult and adolescent cohort in Myanmar.Evaluating the Impact of a HIV Low-Risk Express Care Task-Shifting Program: A Case Study of the Targeted Learning RoadmapTrends and Determinants of Antiretroviral Therapy Patient Monitoring Practices in Kenya and Uganda.Detection of immunological treatment failure among HIV infected patients in Ethiopia: a retrospective cohort studyOutcome of patients on second line antiretroviral therapy under programmatic condition in IndiaEvaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+ T Cell Counts in HIV Infection.Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.Prolonged tuberculosis-associated immune reconstitution inflammatory syndrome: characteristics and risk factors.High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005-2015Specimen origin, type and testing laboratory are linked to longer turnaround times for HIV viral load testing in MalawiLaboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.Should viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settingsSwitching to second-line ART in relation to mortality in a large Tanzanian HIV cohort.Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.The occurrence of Simpson's paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database.Barriers to HIV remission research in low- and middle-income countries.Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps.Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.Delays in switching patients onto second-line antiretroviral treatment at a public hospital in eThekwini, KwaZulu-Natal.Doubly Robust and Efficient Estimation of Marginal Structural Models for the Hazard Function.Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand
P2860
Q33764793-09158900-2D57-4250-B2AB-ADB2DEE6B9DCQ33832833-B1BD3862-BE35-4C7F-A9E4-2D3A12FF4F42Q33867924-B620A7AD-5C1C-4774-9C31-939AA3E81A7BQ33922137-5E5A071D-213C-4F86-9D86-A8AB81D3F675Q35746510-EEA80B18-18E0-48B0-B854-99506E98210EQ35777589-58BB0AEF-B4AC-4165-B366-DF6061F707E0Q35842413-116BE511-C77E-4D87-AB66-496CE767E3FDQ36070274-A64F7688-38A8-4137-B130-A395CA03D9C3Q36109276-2B832286-D279-4F4C-9628-BE5590800588Q36146226-ED2744CF-4939-4F5B-83FF-98B9370FA275Q36275812-F8B5AA50-8D09-4446-8AA5-8E213CE11616Q36289976-E8FBC88B-9E9A-49AB-AA85-8AC311534788Q36915084-A4653AD4-7285-4046-87B0-C721C6D7EBF0Q37116750-9B8D3170-E374-484A-ADF8-21ED37D51F13Q38848107-0B36845F-7C17-442B-B168-9DF851F13B1CQ38849127-0FD50C51-4EC2-435B-B2C4-093159743631Q38858252-486DDB46-5FC9-45CF-BA65-5EDDB0691ACAQ38911057-F328BD78-34CD-4C06-A705-75C8D6C59944Q39366791-47B1FE5D-71AC-4849-BD0A-1F1CCD05211AQ40088992-F5F7375B-CFE1-4247-98EE-D66D4250E73AQ45326389-4B995005-8670-42EC-9943-92AF1E851109Q52604813-2579C62D-058A-445C-9A60-51C044EF7241Q52641456-5D7775B8-9AAB-473C-A4B8-5A0F98A12E8CQ53604858-782F8C1C-E11C-43BE-91DF-27F7C42B999DQ56912416-53A1D8FD-08F3-4FF8-9901-510EDFCD36C7Q57077691-C9DF9933-EA83-4495-A534-0852B702668B
P2860
Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Delayed switch of antiretrovir ...... HIV-infected adults in Africa.
@ast
Delayed switch of antiretrovir ...... HIV-infected adults in Africa.
@en
type
label
Delayed switch of antiretrovir ...... HIV-infected adults in Africa.
@ast
Delayed switch of antiretrovir ...... HIV-infected adults in Africa.
@en
prefLabel
Delayed switch of antiretrovir ...... HIV-infected adults in Africa.
@ast
Delayed switch of antiretrovir ...... HIV-infected adults in Africa.
@en
P2093
P2860
P50
P1433
P1476
Delayed switch of antiretrovir ...... HIV-infected adults in Africa.
@en
P2093
Andrew Kambugu
Elvin H Geng
Jeffrey N Martin
Maya L Petersen
Steven J Reynolds
P2860
P304
P356
10.1097/QAD.0000000000000349
P407
P577
2014-09-01T00:00:00Z